{"id":"W2562165295","doi":"10.1182/blood.v108.11.306.306","title":"Clinical Efficacy of Lenalidomide {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of a Phase II Clinical Trial.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Internal medicine; Fludarabine; Gastroenterology; Rituximab; Rash; Thalidomide; Tumor lysis syndrome; Bendamustine; Chronic lymphocytic leukemia; Pomalidomide; Refractory (planetary science); Progressive disease; Febrile neutropenia; Multiple myeloma; Leukemia; Toxicity; Lymphoma; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00336967,0.0008851683,0.001896672,0.0003844062,0.0002317414,0.0009352473,0.0008119734,0.0009015081,0.001888525],"category_scores_gemma":[0.001257436,0.0003410784,0.001035379,0.0005282885,0.0003817569,0.0005948512,0.0002463061,0.001594414,0.000511226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000608992,"about_ca_system_score_gemma":0.0008078391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008752121,"about_ca_topic_score_gemma":0.002027576,"domain_scores_codex":[0.999289,0.0004190701,0.00006996174,0.00006731223,0.00007683464,0.00007783427],"domain_scores_gemma":[0.9990255,0.0002541002,0.0003200324,0.0000616906,0.00007574438,0.0002629447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4681834,0.01958754,0.04200788,0.003725977,0.005357458,0.0004307457,0.0003295864,0.002652556,0.04072668,0.0002238008,0.01094246,0.405832],"study_design_scores_gemma":[0.6207675,0.2523855,0.09814121,0.0003943942,0.003741272,0.001153916,0.0001112442,0.001476776,0.004588975,0.0002223785,0.01692198,0.00009487877],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9478508,0.04046671,0.0007037969,0.001109057,0.0001769228,0.002034163,0.003645077,0.000164778,0.003848641],"genre_scores_gemma":[0.9675168,0.01538307,0.001998428,0.00210683,0.0003967276,0.001954293,0.008725977,0.00004172125,0.0018761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00336967,"threshold_uncertainty_score":0.01782078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04379604490781398,"score_gpt":0.3750465100802808,"score_spread":0.3312504651724668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}